Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Rhythm Pharmaceuticals focuses on rare genetic obesity disorders and developed Imcivree (setmelanotide), which is FDA-approved for specific conditions like POMC and LEPR deficiency
Preclinical studies in diet-induced obese mice have examined its effects on adipose tissue and glucose tolerance
Some of these factors are the results of surgeries, genetic factors or chronic conditions which might require higher levels of B12 to ensure that enough is being absorbed by the body
Common applications include: Obesity and Body-Weight Regulation Models : Studying how chronic exposure to AOD 9604 affects body weight, fat, and energy use in obese rodents, often using calorimetry (measuring energy expenditure) and body fat measurements
Stable at RT during shipping
US$ 24.08
US$ 26.96
US$ 29.97
US$ 29.41
US$ 24.17
US$ 29.38
US$ 27.56
